FARN — Faron Pharmaceuticals Oy Share News
0.000.00%
Last trade - 00:00- £52.57m
- £63.24m
REG - Faron Pharma. Oy - Decisions of the Board of Directors
AnnouncementREG - Faron Pharma. Oy - Approval of Warrant Terms and Conditions
AnnouncementREG - Faron Pharma. Oy - Appointment of Chief Executive Officer
AnnouncementREG - Faron Pharma. Oy - Results of the Annual General Meeting
AnnouncementREG - Faron Pharma. Oy - Announcement of Placing
AnnouncementREG - Faron Pharma. Oy - Issue of Warrants to IPF Funding Update
AnnouncementREG - Faron Pharma. Oy - Faron´s Annual Report 2023
AnnouncementREG - Faron Pharma. Oy - Additional Positive Data from Phase 1 of BEXMAB
AnnouncementRCS - Faron Pharma. Oy - Faron to Host BEXMAB Webcast
AnnouncementREG - Faron Pharma. Oy - Notice of Annual General Meeting 2024
AnnouncementREG - Faron Pharma. Oy - Financial Statement January 1 to December 31 2023
AnnouncementREG - Faron Pharma. Oy - Binding commitments for convertible loans
AnnouncementREG - Faron Pharma. Oy - Update to Faron’s Financial Calendar for 2024
AnnouncementREG - Faron Pharma. Oy - Continued Negotiations Regarding Events of Default
AnnouncementREG - Faron Pharma. Oy - Events of Default
AnnouncementREG - Faron Pharma. Oy - Further re: Exercise of options
AnnouncementREG - Faron Pharma. Oy - BEXMAB Insights into Patient Profiles
AnnouncementREG - Faron Pharma. Oy - Exercise of options - Issue of equity
AnnouncementREG - Faron Pharma. Oy - First Patient Dosed in Ph 2 of the BEXMAB Trial
Announcement